Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enke Baldini

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
International Journal of Endocrinology|August 7, 2014
A new aurora in anaplastic thyroid cancer therapyEnke Baldini, Massimino D'Armiento, Salvatore Ulisse
Current Cancer Drug Targets|February 10, 2009
The urokinase plasminogen activator system: a target for anti-cancer therapySalvatore Ulisse, Enke Baldini, Salvatore Sorrenti, et al.
Nutrients|July 21, 2019
Iodine Status in Schoolchildren and Pregnant Women of Lazio, a Central Region of ItalyEnke Baldini, Camilla Virili, Eleonora D'Armiento, et al.
Journal of Clinical Medicine|September 9, 2022
Cancer Metabolism and Ischemia-Reperfusion Injury: Two Sides of the Same CoinDenise V Nemeth, Enke Baldini, Salvatore Sorrenti, et al.
Human Reproduction Update|June 20, 2014
Molecular basis of thyrotropin and thyroid hormone action during implantation and early developmentMartina Colicchia, Luisa Campagnolo, Enke Baldini, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 19, 2021
Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma Cell LineZahra Nozhat, Maryam Zarkesh, Enke Baldini, et al.
Current Medicinal Chemistry|February 5, 2016
Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid CancerSilvia Martina Ferrari, Gabriele Materazzi, Enke Baldini, et al.
The Journal of Endocrinology|November 6, 2009
Inhibition of the aurora kinases suppresses in vitro NT2-D1 cell growth and tumorigenicitySalvatore Ulisse, Yannick Arlot-Bonnemains, Enke Baldini, et al.
International Journal of Surgery (London, England)|May 17, 2017
New perspectives in the diagnosis of thyroid follicular lesionsEnke Baldini, Salvatore Sorrenti, Francesco Tartaglia, et al.
Investigational New Drugs|May 14, 2014
The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathwaysSusi Barollo, Loris Bertazza, Enke Baldini, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
International Journal of Endocrinology|August 7, 2014
A new aurora in anaplastic thyroid cancer therapyEnke Baldini, Massimino D'Armiento, Salvatore Ulisse
Current Cancer Drug Targets|February 10, 2009
The urokinase plasminogen activator system: a target for anti-cancer therapySalvatore Ulisse, Enke Baldini, Salvatore Sorrenti, et al.
Nutrients|July 21, 2019
Iodine Status in Schoolchildren and Pregnant Women of Lazio, a Central Region of ItalyEnke Baldini, Camilla Virili, Eleonora D'Armiento, et al.
Journal of Clinical Medicine|September 9, 2022
Cancer Metabolism and Ischemia-Reperfusion Injury: Two Sides of the Same CoinDenise V Nemeth, Enke Baldini, Salvatore Sorrenti, et al.
Human Reproduction Update|June 20, 2014
Molecular basis of thyrotropin and thyroid hormone action during implantation and early developmentMartina Colicchia, Luisa Campagnolo, Enke Baldini, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 19, 2021
Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma Cell LineZahra Nozhat, Maryam Zarkesh, Enke Baldini, et al.
Current Medicinal Chemistry|February 5, 2016
Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid CancerSilvia Martina Ferrari, Gabriele Materazzi, Enke Baldini, et al.
The Journal of Endocrinology|November 6, 2009
Inhibition of the aurora kinases suppresses in vitro NT2-D1 cell growth and tumorigenicitySalvatore Ulisse, Yannick Arlot-Bonnemains, Enke Baldini, et al.
International Journal of Surgery (London, England)|May 17, 2017
New perspectives in the diagnosis of thyroid follicular lesionsEnke Baldini, Salvatore Sorrenti, Francesco Tartaglia, et al.
Investigational New Drugs|May 14, 2014
The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathwaysSusi Barollo, Loris Bertazza, Enke Baldini, et al.
Pageof 8